iBio, Inc. (IBIO)
1.42
-0.01
(-0.70%)
USD |
NASDAQ |
Aug 24, 16:00
1.40
-0.02
(-1.41%)
After-Hours: 20:00
iBio Price : 1.42 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 1.45 | 1.45 | 1.371 | 1.42 | 514909.0 |
| Aug 21, 2026 | 1.46 | 1.500 | 1.42 | 1.43 | 755205.0 |
| Aug 20, 2026 | 1.47 | 1.50 | 1.44 | 1.47 | 1.977M |
| Aug 19, 2026 | 1.47 | 1.50 | 1.42 | 1.49 | 839379.0 |
| Aug 18, 2026 | 1.45 | 1.47 | 1.40 | 1.45 | 2.795M |
| Aug 17, 2026 | 1.45 | 1.475 | 1.423 | 1.45 | 589284.0 |
| Aug 14, 2026 | 1.38 | 1.44 | 1.34 | 1.43 | 522573.0 |
| Aug 13, 2026 | 1.48 | 1.48 | 1.38 | 1.40 | 507811.0 |
| Aug 12, 2026 | 1.47 | 1.54 | 1.455 | 1.47 | 599651.0 |
| Aug 11, 2026 | 1.41 | 1.505 | 1.37 | 1.47 | 375066.0 |
| Aug 10, 2026 | 1.41 | 1.43 | 1.39 | 1.40 | 479117.0 |
| Aug 07, 2026 | 1.40 | 1.425 | 1.375 | 1.41 | 436395.0 |
| Aug 06, 2026 | 1.40 | 1.412 | 1.36 | 1.39 | 424306.0 |
| Aug 05, 2026 | 1.46 | 1.48 | 1.39 | 1.40 | 304807.0 |
| Aug 04, 2026 | 1.46 | 1.49 | 1.44 | 1.46 | 486242.0 |
| Aug 03, 2026 | 1.44 | 1.44 | 1.38 | 1.42 | 470289.0 |
| Jul 31, 2026 | 1.41 | 1.47 | 1.34 | 1.40 | 728594.0 |
| Jul 30, 2026 | 1.36 | 1.415 | 1.35 | 1.39 | 422403.0 |
| Jul 29, 2026 | 1.39 | 1.41 | 1.29 | 1.36 | 802898.0 |
| Jul 28, 2026 | 1.45 | 1.45 | 1.33 | 1.39 | 1.013M |
| Jul 27, 2026 | 1.44 | 1.47 | 1.35 | 1.45 | 1.046M |
| Jul 24, 2026 | 1.40 | 1.465 | 1.31 | 1.43 | 1.213M |
| Jul 23, 2026 | 1.35 | 1.41 | 1.33 | 1.40 | 464670.0 |
| Jul 22, 2026 | 1.40 | 1.407 | 1.35 | 1.38 | 370363.0 |
| Jul 21, 2026 | 1.38 | 1.42 | 1.35 | 1.41 | 384732.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Capricor Therapeutics, Inc. | 6.80 |
| Ocugen, Inc. | 1.36 |
| CytomX Therapeutics, Inc. | 3.29 |
| ACADIA Pharmaceuticals, Inc. | 29.65 |
| Alnylam Pharmaceuticals, Inc. | 236.01 |
Price Related Metrics
| PS Ratio | 340.96 |
| Price to Book Value | 0.6326 |
| Earnings Yield | -40.68% |
| Market Cap | 49.05M |